BOSTON, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Vor Bio (NASDAQ:VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in the following investor conferences:

Wells Fargo 21st Annual Healthcare Conference

                        Forum: Fireside Chat and 1x1 Meetings

                        Date: Tuesday, September 8th

                        Presentation Time: 8:00AM ET

Citi’s 2026 Biopharma Back to School Conference

                        Forum: Fireside Chat and 1x1 Meetings

                        Date: Wednesday, September 9th

                        Presentation Time: 11:20AM ET

Morgan Stanley 24th Annual Global Healthcare Conference

Forum: 1x1 Meetings

Date: Monday, September 14th

Baird’s 2026 Global Healthcare Conference

                        Forum: Presentation and 1x1 Meetings

                        Date: Tuesday, September 15th

                        Presentation Time: 9:05AM ET

Stifel’s 2026 Virtual Immunology and Inflammation Forum

Forum: Presentation and 1x1 Meetings

Date: Wednesday, September 23rd

Presentation Time: 11:30AM ET

A live webcast of the presentation may be accessed on the Investors section of the Vor website at ir.vorbio.com. A replay of the webcast will be available on the Vor website for approximately 30 days following the presentation.

About Vor Bio

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The Company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. For more information visit www.vorbio.com. Vor Bio routinely posts information that may be important to investors in the "Investors" section of its website. The Company encourages investors to consult that section of its website regularly.

Media & Investor Contacts:
Carl Mauch
cmauch@vorbio.com